Company / Book Value per Share
Cue Biopharma, Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.428
FY2025
5-year range
$0.371 / $2.158
FY2021-FY2025
Trend
+15.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $0.428.
Based on SEC 10-K filings.
$0.428 in FY2025 with a 5-year CAGR of -26.9%.
Declined from $0.785 to $0.428 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -40.6%
- 5-Year CAGR
- -26.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -26.9%, indicating a declining trend.
- In FY2025, book value per share increased 15.4% year-over-year.
- Peak book value per share was recorded in FY2021.
- Lowest book value per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -7.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.428 | +15.4% |
| FY2024 | $0.371 | -52.8% |
| FY2023 | $0.785 | -61.5% |
| FY2022 | $2.04 | -5.5% |
| FY2021 | $2.158 | +5.0% |
| FY2020 | $2.055 | +25.2% |
| FY2019 | $1.641 | +110.5% |
| FY2018 | $0.78 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026